Navigation Links
New licensing agreement could improve treatment options for children living with HIV
Date:7/25/2014

Washington, D.C.-- July 25, 2014 -- The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) applauds the new licensing agreement between the Medicines Patent Pool (MPP) and Gilead Sciences, Inc. to improve access to tenofovir alafenamide fumarate (TAF), a promising new HIV medication. The agreement was announced during the 20th International AIDS Conference (AIDS 2014) in Melbourne, Australia.

While TAF is still in Phase III clinical trials, early data suggests it could be a key ingredient in the next generation of first-line fixed-dose treatment options for children living with HIV.

"With only one in four children living with HIV currently getting treatment, we cannot continue to do business as usual," said Charles Lyons, EGPAF president and CEO. "We congratulate MPP and Gilead on this expanded collaboration and their proactive efforts to support countries and populations hardest hit by HIV and AIDS. This is the kind of innovative action that we need now to protect the health of affected children and in order to achieve an AIDS-free generation. "

The license will allow manufacturers in India and China to develop generic versions of TAF for 112 countries that are home to more than 92 percent of people living with HIV in the developing world.

Every day, almost 700 babies are newly infected with HIV, almost all of whom live in sub-Saharan Africa. EGPAF and its affiliates have provided critical HIV care and treatment to more than 2 million individuals, including 160,000 children and enrolled more than 95,000 children on antiretroviral therapy.


'/>"/>
Contact: Johanna Harvey
jharvey@pedaids.org
202-280-1657
Elizabeth Glaser Pediatric AIDS Foundation
Source:Eurekalert

Page: 1

Related medicine news :

1. BioPharm Insight Releases Quarterly Licensing Information on Global Drug Development
2. Edison Nation Medical Secures Licensing Agreement with Medline Industries, Inc. for New Hospital Isolation Gown Invented by Nurse to Address Hospital Infections
3. Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2013
4. Colorado Colorado State Regulators Decide up Licensing Fees and Rules for Upcoming Recreational Pot Business, as reported by PotStores.com
5. OdorNo® Signs Exclusive Agreement with BaseCamp™: Licensing of OdorNo® Technology for BaseCamp™ Odor Barrier Bags™ for Camping, Fishing, Hunting and the Outdoors
6. Amco Agency announce an Immediate Sale or Licensing Opportunity: Fluorescent Lifetime Test / Drug Screening Equipment and Consumables
7. Central Oregon Management Consultant Earns TIGERS Success Series Team Development and Team Effectiveness Certification and Licensing
8. Biofeedback Federation of Europe Enters Distribution Agreement with Zukor Interactive
9. Global food safety research agreement signed by China and UC Davis
10. Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow
11. League of Voluntary Hospitals and Homes and 1199SEIU Reach New Four-Year Collective Bargaining Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... (PRWEB) , ... September 22, 2017 , ... ... preserve fertility and create life. Although frozen embryos have a slight statistical advantage ... , “Egg freezing is a wonderful opportunity for women undergoing medical treatment or ...
(Date:9/21/2017)... Aliso Viejo, CA (PRWEB) , ... September 21, 2017 , ... ... never been so fun and easy to do. Users can select from up to ... more all with a click of a mouse all within Final Cut Pro ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... Sept. 26, 2017 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      ... easy to get things wrong, run afoul of The Quality System Regulation (§820.250), ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... Infinity Behavioral Health Services for professionals in the addiction treatment industry entitled: ... . , Insurance companies and state and federal governments are increasingly scrutinizing ...
(Date:9/21/2017)... IL. (PRWEB) , ... September 21, 2017 , ... ... results released today of a new member survey conducted by the International ... restoration procedures performed from 2014 to 2016 rose 60 percent, with 635,189 procedures ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... -- Sapheneia and Scannerside received FDA 510(k) clearance to ... third-party Vendor neutral CT product that makes it affordable ... current MITA standards. ... specifically designed to provide CT operators, prior to a ... a predefined threshold. Scannerside Dose Check is intended to ...
(Date:9/5/2017)... , Sept. 5, 2017  Getinge, a ... created a vibrant charitable donation program -- "Color ... support congenital heart defect research by The Children,s ... and the general public are encouraged to download ... submit the completed artwork to the gallery on ...
(Date:9/5/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... its meeting with the U.S. Food and Drug Administration ... At the meeting, ... for submission of ORMD-0801, would be a Biologics License ...
Breaking Medicine Technology: